GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 802 filers reported holding GLAXOSMITHKLINE PLC in Q2 2019. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $203,000 | -1.9% | 5,510 | 0.0% | 0.03% | -20.0% |
| Q3 2020 | $207,000 | -8.0% | 5,510 | 0.0% | 0.04% | -13.0% |
| Q2 2020 | $225,000 | +9.8% | 5,510 | +2.0% | 0.05% | -11.5% |
| Q1 2020 | $205,000 | -31.9% | 5,400 | -15.6% | 0.05% | +30.0% |
| Q4 2019 | $301,000 | +10.3% | 6,400 | 0.0% | 0.04% | +29.0% |
| Q3 2019 | $273,000 | +6.6% | 6,400 | 0.0% | 0.03% | +10.7% |
| Q2 2019 | $256,000 | -4.1% | 6,400 | 0.0% | 0.03% | +3.7% |
| Q1 2019 | $267,000 | +9.0% | 6,400 | 0.0% | 0.03% | -3.6% |
| Q4 2018 | $245,000 | -37.8% | 6,400 | -34.7% | 0.03% | -3.4% |
| Q3 2018 | $394,000 | -0.3% | 9,800 | 0.0% | 0.03% | 0.0% |
| Q2 2018 | $395,000 | +3.1% | 9,800 | 0.0% | 0.03% | -3.3% |
| Q1 2018 | $383,000 | – | 9,800 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |